Search research articles
Contact Us
Filters
Showing results (111-120 of 143) with videos related to
Page
of 15
Sort By:
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen
|
January 15, 2020
[Introduction of an interdisciplinary tumor board leads to improvement of treatment outcome of cholangiocarcinoma (bile duct cancer)]
Mazen A Juratli, Konstantin Hofmann, Ümniye Balaban, et al.
Transplantation
|
February 7, 2018
Extended Pancreas Donor Program-The EXPAND Study: A Prospective Multicenter Trial Testing the Use of Pancreas Donors Older Than 50 Years
Andrea Proneth, Andreas A Schnitzbauer, Peter Schenker, et al.
Annals of Surgical Oncology
|
October 25, 2019
The MEGNA Score and Preoperative Anemia are Major Prognostic Factors After Resection in the German Intrahepatic Cholangiocarcinoma Cohort
Andreas A Schnitzbauer, Johannes Eberhard, Fabian Bartsch, et al.
The Lancet. Oncology
|
October 15, 2013
Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial
Bernard Nordlinger, Halfdan Sorbye, Bengt Glimelius, et al.
Journal of Clinical Medicine
|
May 27, 2023
Treatment of Non-Anastomotic Biliary Strictures after Liver Transplantation: How Effective Is Our Current Treatment Strategy?
Florian A Michael, Mireen Friedrich-Rust, Hans-Peter Erasmus, et al.
Annals of Surgical Oncology
|
August 5, 2025
Textbook Outcome After Major Liver Resection for Primary and Secondary Liver Tumors at Specialized German Hepatobiliary Centers: Analysis of the StuDoQ Liver Registry
Jan Heil, Svenja Sliwinski, Jan D'Haese, et al.
Annals of Surgery
|
February 9, 2012
Predictive factors for the benefit of perioperative FOLFOX for resectable liver metastasis in colorectal cancer patients (EORTC Intergroup Trial 40983)
Halfdan Sorbye, Murielle Mauer, Thomas Gruenberger, et al.
BMC Cancer
|
January 28, 2026
Longitudinal monitoring of circulating tumor cell dynamics for potential prediction of early recurrence and clinical outcomes after curative resection of hepatocellular carcinoma: a pilot study
Dhruvajyoti Roy, Olaf Guckelberger, Elsie Oppermann, et al.
Lancet (London, England)
|
March 25, 2008
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial
Bernard Nordlinger, Halfdan Sorbye, Bengt Glimelius, et al.
Annals of Surgical Oncology
|
October 6, 2025
ASO Visual Abstract: Textbook Outcome After Major Liver Resection for Primary and Secondary Liver Tumors at Specialized German Hepatobiliary Centers-Analysis of the StuDoQ Liver Registry
Jan Heil, Svenja Sliwinski, Jan D'Haese, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 143) with videos related to
Sort By:
Page
of 15
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen
|
January 15, 2020
[Introduction of an interdisciplinary tumor board leads to improvement of treatment outcome of cholangiocarcinoma (bile duct cancer)]
Mazen A Juratli, Konstantin Hofmann, Ümniye Balaban, et al.
Transplantation
|
February 7, 2018
Extended Pancreas Donor Program-The EXPAND Study: A Prospective Multicenter Trial Testing the Use of Pancreas Donors Older Than 50 Years
Andrea Proneth, Andreas A Schnitzbauer, Peter Schenker, et al.
Annals of Surgical Oncology
|
October 25, 2019
The MEGNA Score and Preoperative Anemia are Major Prognostic Factors After Resection in the German Intrahepatic Cholangiocarcinoma Cohort
Andreas A Schnitzbauer, Johannes Eberhard, Fabian Bartsch, et al.
The Lancet. Oncology
|
October 15, 2013
Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial
Bernard Nordlinger, Halfdan Sorbye, Bengt Glimelius, et al.
Journal of Clinical Medicine
|
May 27, 2023
Treatment of Non-Anastomotic Biliary Strictures after Liver Transplantation: How Effective Is Our Current Treatment Strategy?
Florian A Michael, Mireen Friedrich-Rust, Hans-Peter Erasmus, et al.
Annals of Surgical Oncology
|
August 5, 2025
Textbook Outcome After Major Liver Resection for Primary and Secondary Liver Tumors at Specialized German Hepatobiliary Centers: Analysis of the StuDoQ Liver Registry
Jan Heil, Svenja Sliwinski, Jan D'Haese, et al.
Annals of Surgery
|
February 9, 2012
Predictive factors for the benefit of perioperative FOLFOX for resectable liver metastasis in colorectal cancer patients (EORTC Intergroup Trial 40983)
Halfdan Sorbye, Murielle Mauer, Thomas Gruenberger, et al.
BMC Cancer
|
January 28, 2026
Longitudinal monitoring of circulating tumor cell dynamics for potential prediction of early recurrence and clinical outcomes after curative resection of hepatocellular carcinoma: a pilot study
Dhruvajyoti Roy, Olaf Guckelberger, Elsie Oppermann, et al.
Lancet (London, England)
|
March 25, 2008
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial
Bernard Nordlinger, Halfdan Sorbye, Bengt Glimelius, et al.
Annals of Surgical Oncology
|
October 6, 2025
ASO Visual Abstract: Textbook Outcome After Major Liver Resection for Primary and Secondary Liver Tumors at Specialized German Hepatobiliary Centers-Analysis of the StuDoQ Liver Registry
Jan Heil, Svenja Sliwinski, Jan D'Haese, et al.
Page
of 15